Discussion of benefits in the context of risks of LABAs for the treatment of asthma

First Page		Document Content
Date: 2009-01-05 11:05:20 Combination drugs Asthma Phenethylamines Salmeterol Phenols GlaxoSmithKline Fluticasone/salmeterol Formoterol Budesonide/formoterol Medicine Pulmonology Respiratory therapy		Discussion of benefits in the context of risks of LABAs for the treatment of asthma Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 256,54 KB Share Document on Facebook

	THE SAUDI GROUP FOR INTERVENTIONAL PULMONOLOGY (SGIP) organiZE Pleural Procedures Workshop 11 November 2017 \| Prince Sultan Military Medical City, Riyadh, Saudi Arabia Lectures DocID: 1ueJP - View Document
	Microsoft WordSpiriva final redline new IFU.docx DocID: 1rn7z - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PROAIR RESPICLICK safely and effectively. See full prescribing information for PROAIR RESPICLICK. PROAIR RESPICLICK DocID: 1rmwD - View Document
	chemicaldiagram type fixed DocID: 1rjJW - View Document
	Color profile: Disabled Composite Default screen CTS GUIDELINES FOR OCCUPATIONAL ASTHMA Canadian Thoracic Society DocID: 1r9jS - View Document